The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...
More information about the 2025 AAAAI / WAO Joint Congress can be accessed here.
The focus of the presentation will be on the subgroup of patients who have received 100mg bezuclastinib for at least 48 weeks to highlight the symptomatic benefits of long-term use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback